These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 402747)

  • 21. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
    Furnari S; Lattuca C; Pavone-Macaluso M; Leone G
    Arch Ital Urol Nefrol; 1968; 41(3):187-98. PubMed ID: 4982415
    [No Abstract]   [Full Text] [Related]  

  • 23. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP; Calcat P; Martel JP
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract]   [Full Text] [Related]  

  • 24. Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.
    Edsmyr F; Boman J
    Acta Radiol Ther Phys Biol; 1970 Oct; 9(5):395-400. PubMed ID: 4990891
    [No Abstract]   [Full Text] [Related]  

  • 25. [Depression of bone marrow after intravesical use of Thio-tepa].
    Malling N
    Ugeskr Laeger; 1980 Sep; 142(40):2630-1. PubMed ID: 6777928
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fatal bone marrow aplasia due to endovesical thio-tepa].
    Navas P; Grasset D
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):489-91. PubMed ID: 4216649
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J
    Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
    Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G
    Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
    [No Abstract]   [Full Text] [Related]  

  • 30. [Verification of the effectiveness of Thio-Tepa on tumor tissue in local chemotherapy of bladder papillomatosis].
    Lunglmayr G; Kellner G; Czech K
    Urol Int; 1970; 25(5):493-501. PubMed ID: 5004171
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thio-tepa treatment for prevention of recurrence of surgically treated bladder tumors].
    Neagoe M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1980; 29(4):259-65. PubMed ID: 6457322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental animal and clinical studies of the absorption of trisaziridylthiophosphoric acid (Thio-Thepa) from the bladder].
    Lunglmayr G; Czech K
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(6):421-8. PubMed ID: 4996544
    [No Abstract]   [Full Text] [Related]  

  • 34. [Personal experience with thio-tepa in the treatment of papillomas and superficial carcinomas of the bladder].
    Pellet A; Djulepa J
    Ther Umsch; 1970 May; 27(5):310-3. PubMed ID: 4994886
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.
    Drew JE; Marshall VF
    J Urol; 1968 Jun; 99(6):740-3. PubMed ID: 4968248
    [No Abstract]   [Full Text] [Related]  

  • 36. Intracavitary mitomycin-C in the treatment of superficial urothelial tumors: a preliminary report.
    Kaufman JJ; Walther PJ; Smith RB; Skinner DG
    Trans Am Assoc Genitourin Surg; 1979; 71():6-7. PubMed ID: 545816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usual harmlessness of endovesical instillations of thio-tepa].
    des Roseaux M; Vacant J; Beurton D; Cukier J
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):485-7. PubMed ID: 4216647
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 40. [BCG in superficial carcinoma of the bladder. Authors' experience].
    Bordalba Gómez JR; Muñoz Segui J; Aguilo F; Gil Vernet A; Vigues F; Lopez Costea MA; Serrallach N
    Actas Urol Esp; 1992 Jun; 16(6):443-5. PubMed ID: 1509911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.